A 3-year study of the digital health app from Israel’s Hello Heart (see here previously) shows that over 84% of participants with stage II hypertension achieved a reduction in their systolic blood pressure. It was the largest multi-year efficacy study of a digital therapeutic to control hypertension.
https://www.calcalistech.com/ctech/articles/0,7340,L-3920395,00.html
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2785012